GlaxoSmithKline (GSK) has released an update.
Top executives at GSK plc, including CEO Emma Walmsley and CFO Julie Brown, have acquired Ordinary Shares under the company’s Share Reward Plan as of April 10, 2024. The transactions, which involved partnership and matching shares, took place at the London Stock Exchange with shares priced at £16.1277 each. This move could signal confidence in the company’s performance and future prospects.
For further insights into GSK stock, check out TipRanks’ Stock Analysis page.
